Drug Shortage Report for MYLAN-ATOVAQUONE/PROGUANIL

Last updated on 2025-05-06 History
Report ID 255409
Drug Identification Number 02402165
Brand name MYLAN-ATOVAQUONE/PROGUANIL
Common or Proper name ATOVAQUONE/PROGUANIL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) PROGUANIL HYDROCHLORIDE ATOVAQUONE
Strength(s) 100MG 250MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100BT
ATC code P01BB
ATC description ANTIMALARIALS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2025-05-05
Actual start date
Estimated end date 2025-08-12
Actual end date
Shortage status Actual shortage
Updated date 2025-05-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-05-06 English Compare
v4 2025-04-28 French Compare
v3 2025-04-28 English Compare
v2 2025-04-23 French Compare
v1 2025-04-23 English Compare

Showing 1 to 5 of 5